EquiVac Innovator EHV-1/4

Company: Zoetis

Equine Rhinopneumonitis Vaccine

Killed Virus

This product has been shown to be effective for the vaccination of healthy horses 10 months of age or older against equine rhinopneumonitis caused by type 1 and 4 viruses. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Field safety testing has demonstrated that this product is safe for use in horses 3 months of age or older. Efficacy has not been established in foals 3 months of age.

Directions For Use

Shake well. Aseptically administer 1 mL intramuscularly. Healthy horses should receive two doses administered 3-4 weeks apart. For advice on revaccination frequency or in the face of stress or exposure, contact your veterinarian or the manufacturer.

Precautions

Use entire contents when first opened. Transient local reactions may occur at the injection site. This product has not been tested in pregnant animals. In case of allergic reaction, administer epinephrine. Do not mix with other products. In case of human exposure, contact a physician.

Store at 2°-8°C. Do not freeze. Do not vaccinate within 21 days before slaughter. Contains thimerosal, neomycin, and polymyxin B as preservatives.

Technical inquiries: (888) 963-8471

VLN 190/PCN 1525.24

Zoetis Inc., Kalamazoo, MI 49007, USA

For Veterinary Use Only

CPN: 3690283.4